EPO takes position on epi paper concerning ST26 sequence listings
August 04, 2022
As reported previously (see here) epi has raised concerns with the EPO that the implementation, as of 1st July 2022, of Standard ST 26 on sequence listings might impose an undue burden on applicants and trigger added matter issues.
epi position paper on this topic can be found in issue 2/2022 of epi information (see here) .
epi has now received a response from the EPO, which can be found here.
Posted by Marc Névant for the Editorial Committee